Sickle Cell Disease Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020 – 2030
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The US Sickle Cell Disease (SCD) market size was valued at $227.7 million in 2020 and is expected to achieve a CAGR of more than 33% during 2020-2030. Sickle cell disease (SCD) is a genetic, lifelong blood disorder that results in the formation of sickled red blood cells causing severe complications across multiple organ systems. It is inherited in an autosomal recessive pattern, where a single-nucleotide polymorphism in the β-globin gene causes glutamic acid to be replaced by valine, a hydrophobic amino acid. It is inherited when a child receives two SCD genes—one from each parent—and is most often diagnosed at birth with a simple blood test.
The SCD market research report will help you to drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies that are likely to impact the global SCD market in the future. The report will also help you to identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
US Sickle Cell Disease Market Overview, 2020 ($ Million)
To gain more information on the SCD market forecast, download a free report sample
SCD Market Drivers
The launch of six new treatments is expected across the forecast period. This includes two first-in-class gene therapies (bb1111 and CTX001), which will drive a significant increase in the overall market size of SCD as more therapeutic options become available to patients.
SCD Market Segmentation by Type
The key types of the SCD market are HbSS, HbSC, HbSβ0 thal, and HbSβ+ thal. In 2020, the HbSS led the SCD market.
Sickle Cell Disease Market Analysis by Type, 2020 (%)
For more insights into the segments, download a free report sample
Hand SCD Market Segmentation by Drug
The key drugs in the SCD market are Oxbryta (voxelotor), Droxia (hydroxyurea), Endari (L-glutamine), and Adakveo (crizanlizumab). In 2020, Oxbryta (voxelotor) had the largest market share.
Hand Sickle Cell Disease Market Analysis by Drug, 2020 (%)
For more drug segment insights into the hand SCD market, download a free report sample
Competitive Landscape
Some of the leading players in the SCD market are Bluebird Bio/Pasteur Institute, Genmab/Roche And Global Blood Therapeutics, Forma Therapeutics, Agios Pharmaceuticals, H.Lundbeck/Imara, CRISPR/Vertex, Editas Medicine, Sangamo/Sanofi And Bioverativ, and Stanford/Graphite Bio.
SCD Market Report Overview
Market Size (2020) | $227.7 million |
CAGR (2020 – 2030) | >33% |
Forecast Period | 2021-2030 |
Key Type | HbSS, HbSC, HbSβ0 thal, and HbSβ+ thal |
Key Drug | Oxbryta (voxelotor), Droxia (hydroxyurea), Endari (L-glutamine), and Adakveo (crizanlizumab) |
Leading Players | Bluebird Bio/Pasteur Institute, Genmab/Roche And Global Blood Therapeutics, Forma Therapeutics, Agios Pharmaceuticals, H.Lundbeck/Imara, CRISPR/Vertex, Editas Medicine, Sangamo/Sanofi, and Bioverativ, and Stanford/Graphite Bio |
SCD Market Types Outlook ( Value, $ Million, 2020-2030)
- HbSS
- HbSC
- HbSβ0 thal
- HbSβ+ thal
SCD Market Drugs Outlook ( Value, $ Million, 2020-2030)
- Oxbryta (voxelotor)
- Droxia (hydroxyurea)
- Endari (L-glutamine)
- Adakveo (crizanlizumab)
Scope
- GlobalData’s SCD market size and trend report including epidemiology and pipeline analysis, competitor assessment, unmet needs, clinical trial strategies, and forecast, 2020 – 2030 combines data from the pharma intelligence center with in-house analyst expertise to provide a competitive assessment of the disease marketplace
Reasons to Buy
The report will enable you to:
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global SCD market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global SCD market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Emmaus Life Sciences
Global Blood Therapeutics
Novartis Pharmaceuticals
bluebird bio
Genmab/Roche
Forma Therapeutics
Agios Pharmaceuticals
H.Lundbeck/Imara
CRISPR/Vertex
Editas Medicine
Graphite Bio
Sangamo/Sanofi
Bioverativ
Table of Contents
Table
Figures
Frequently asked questions
-
What was the US SCD market size in 2020?
The SCD market size in the US was valued at $227.7 million in 2020.
-
What is the SCD market growth rate?
The SCD market is expected to achieve a CAGR of more than 33% during 2020-2030.
-
What are the key types in the SCD market?
The key types in the SCD market are HbSS, HbSC, HbSβ0 thal, and HbSβ+ thal.
-
What are the key drugs in the hand SCD market?
The key drugs in the SCD market are Oxbryta (voxelotor), Droxia (hydroxyurea), Endari (L-glutamine), and Adakveo (crizanlizumab).
-
Who are the leading players in the SCD market?
Some of the leading players in the SCD market are Bluebird Bio/Pasteur Institute, Genmab/Roche And Global Blood Therapeutics, Forma Therapeutics, Agios Pharmaceuticals, H.Lundbeck/Imara, CRISPR/Vertex, Editas Medicine, Sangamo/Sanofi And Bioverativ, and Stanford/Graphite Bio.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.